Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from WuXi AppTec Co., Ltd. Class H ( (HK:2359) ).
WuXi AppTec has updated its timetable for the payment of its final cash dividend for the financial year ended 31 December 2025, declaring RMB 15.7927 per 10 shares, equivalent to HKD 18.028 per 10 shares for Hong Kong shareholders based on a specified exchange rate. The H shares will trade ex-dividend on 13 May 2026, with the record date set for 15 May 2026 and the dividend payment scheduled for 29 May 2026, while the company also clarified applicable withholding tax rates for different categories of domestic and overseas investors.
The company detailed that non-resident enterprise shareholders on the H share register will be subject to 10% PRC enterprise income tax withheld at source, and investors in its A shares via the Hong Kong Stock Exchange will also face a 10% withholding rate. Mainland investors trading the company’s H shares through the Shanghai and Shenzhen stock exchanges will have a 20% individual income tax withheld on dividends, underscoring the need for shareholders to understand tax treatments across different market access channels.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$150.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a pharmaceutical and life-sciences services provider, offering contract research, development and manufacturing solutions to global biopharmaceutical companies. The company focuses on enabling drug discovery and development through its integrated platform, serving both domestic Chinese and international healthcare markets.
Average Trading Volume: 4,880,283
Technical Sentiment Signal: Buy
Current Market Cap: HK$342B
See more insights into 2359 stock on TipRanks’ Stock Analysis page.

